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Abstract. Neuromodulators have become an increasingly important component of
functional circuits, dramatically changing the properties of both neurons and synap-
ses to affect behavior. To explore the role of neuropeptides in Ascaris suum behavior,
we devised an improved method for cleanly dissecting single motorneuronal cell
bodies from themany other cell processes and hypodermal tissue in the ventral nerve
cord. We determined their peptide content using matrix-assisted laser desorption/
ionization time-of-flight (MALDI-TOF) mass spectrometry (MS). The reduced com-
plexity of the peptide mixture greatly aided the detection of peptides; peptide levels
were sufficient to permit sequencing by tandem MS from single cells. Inhibitory
motorneurons, known to be GABAergic, contain a novel neuropeptide, As-NLP-22
(SLASGRWGLRPamide). From this sequence and information from the A. suum expressed sequence tag (EST)
database, we cloned the transcript (As-nlp-22) and synthesized a riboprobe for in situ hybridization, which labeled
the inhibitory motorneurons; this validates the integrity of the dissection method, showing that the peptides
detected originate from the cells themselves and not from adhering processes from other cells (e.g., synaptic
terminals). Synthetic As-NLP-22 has potent inhibitory activity on acetylcholine-induced muscle contraction as
well as on basal muscle tone. Both of these effects are dose-dependent: the inhibitory effect on ACh contraction
has an IC50 of 8.3 × 10
–9 M. When injected into whole worms, As-NLP-22 produces a dose-dependent inhibition
of locomotory movements and, at higher levels, complete paralysis. These experiments demonstrate the utility of
MALDI TOF/TOF MS in identifying novel neuromodulators at the single-cell level.
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Introduction
In the mid-20th century, there was a resurgence in interest insimple nervous systems, typically found in invertebrates,
where the numbers of neurons are low [1, 2]. The hope was
that the low numbers would allow anatomical descriptions of
the individual neurons and their synaptic connections to be
combined with electrophysiological measurements to give a
“functional wiring diagram,” and that this would give us an
understanding of the way the nervous system controls behav-
ior. Progress has been slow: it is now recognized that the
simplicity of these nervous systems is more apparent than real
[3]. A large part of the complexity of even these “simple
nervous systems” comes from the existence of a large number
of modulating signaling molecules, typically peptides and
amines, which affect the neurons and synapses in subtle and
Christopher J. Konop and Jennifer J. Knickelbine contributed equally to this
work.
Electronic supplementary material The online version of this article
(doi:10.1007/s13361-015-1177-z) contains supplementary material, which is
available to authorized users.
Correspondence to: Antony Stretton; e-mail: aostrett@wisc.edu
complicated ways, each of which needs to be worked out. The
description of the functional wiring diagram was incomplete
because it did not include the role of these neuromodulators.
The inadequacy of the naïve “functional wiring diagram”
approach and the importance of the role of neuropeptides and
other modulators in affecting circuit properties have been par-
ticularly well described in the stomatogastric ganglion (STG)
of Crustacea [4–12]. In this ganglion, the cell numbers are
small (N = 30) and despite the complicated morphology of
the neurons, their synaptic connectivity has been determined,
both anatomically and physiologically [11, 12]. However,
enormous complexity is introduced by the large number of
modulators that reach STG neurons from neurons in other
ganglia [7, 13–16]. These modulators can dramatically change
the properties of the neurons and synapses in the STG, and each
one may produce complex and different responses on different
targets, reconfiguring the network into different functional
circuits. This is the important concept of “circuit switching”
[12, 17, 18]. The analysis of the system is ongoing as more
modulators are discovered [4–7, 19, 20].
Our attempt to simplify the analysis of circuitry has taken
advantage of the properties of the nervous system of the nem-
atode Ascaris suum. Like that of other nematodes, its nervous
system is extremely simple, both numerically (adult female
A. suum has a total of 298 neurons [21]; the Caenorhabditis
elegans hermaphrodite has 302 neurons [22]) and morpholog-
ically (typical neurons have no more than two branch points);
yet they have an extensive array of neuropeptides [23–29]. In
order to understand a particular neuronal circuit at the cellular
level, the salient peptides must be identified, and their biolog-
ical activities analyzed. These are crucial parts of the structure–
function description of a circuit that are needed to create a
meaningful functional wiring diagram. Similarly, the identifi-
cation of the neurons that express each neuropeptide (i.e., the
cellular expression pattern), is functionally important.
We are concentrating on one aspect of the behavior of
A. suum, the control of locomotion. A. suum exhibits a simple
locomotory behavior characterized by a propagating two-
dimensional waveform produced by alternating contractions
and relaxations of dorsal and ventral muscles; these muscles
are controlled by serial sets of dorsal and ventral excitatory and
inhibitory motorneurons distributed along the length of the
body [30]. The cell bodies of these motorneurons are relatively
large and are found in a highly reproducible ordered array in
the ventral cord; this has allowed for extensive biochemical and
physiological characterization of these neurons [30–37]. After
locating the classic neurotransmitters in individual
motorneurons and investigating their function, we have taken
several paths to identifying endogenous peptides. Initially, we
used chemical isolation by multi-step high pressure liquid
chromatography (HPLC), followed by the use of specific anti-
bodies and in situ hybridization [27, 28, 38, 39]. More recently,
we have used mass spectrometry (MS), first on isolated ganglia
and then on single identified neurons [23, 40, 41], and have
identified and sequenced over 100 peptides from A. suum; this
is a fraction of the over 250 putative peptides that are predicted
[29, 40, 42]. Already it is clear that most of the neuropeptides
that have been tested affect the physiological properties of the
motorneurons and/or muscle cells, although many of these
peptides are expressed in neurons that are not an obvious part
of the locomotory circuitry. We have now improved the dis-
section techniques so that we can isolate individual identified
motorneurons from the ventral nerve cord, and isolate and
sequence their endogenous neuropeptides.
As in other organisms, peptides in nematodes are generated
from precursor proteins by proteolysis and other post-
translational processing steps [29, 43]. Nematode peptides
and genes are highly conserved within the phylum and many
are grouped into three large families, originally described in
C. elegans [44–46]: the peptides in two of these families,
FMRFamide-like peptides (flps) and insulin-like peptides
(ins), are sequence-related within their respective families. A
third family consists of a more diverse group of neuropeptide-
like proteins (nlps); in this group, there are subfamilies of
related peptides, but the subfamilies have little sequence sim-
ilarity to each other [29, 44].
In order to identify the endogenous peptides of
motorneurons, we have dissected single motorneurons and
analyzed them by single-cell mass spectrometry. This was
made possible by a necessary refinement, described in this
paper, of the single cell dissection technique previously devel-
oped in A. suum [23, 41], and used in conjunction with matrix-
assisted laser desorption/ionization time-of-flight (MALDI-
TOF) MS. The quantities of peptide present in single cells are
sufficient not only to identify individual peptides in individual
identified neurons by their molecular mass but also to deter-
mine their sequence by tandem MS (MS/MS). We confirm the
de novo sequence determination by tandem MS of synthetic
peptide, showing that the fragmentation pattern is the same.
Determination of the peptide sequence byMS is what leads this
work; the sequence is enabling, since it permits searching of
nucleic acid databases for the encoding transcripts, which can
be used for the synthesis of riboprobes for in situ hybridization;
it also is essential for making synthetic peptide for functional
studies, since the quantities of peptide readily available from
biological material are not sufficient (unless heroic purifica-
tions are carried out).
We report here the identification, localization, and bioactiv-
ity of a peptide expressed in the GABAergic VI and DI inhib-
itory ventral cord motorneurons. This peptide, As-NLP-22
(SLASGRWGLRPamide), is encoded by the A. suum
neuropeptide-like protein gene As-nlp-22, and is cleaved from
the precursor protein encoded by this gene. We have confirmed
the cellular expression of this gene by in situ hybridization; this
is an important validation of the adequacy of the single neuron
dissection technique, since it shows that the mass spectra are
not massively contaminated by peptides present in processes
(e.g., synaptic terminals) from neighboring neurons. Pharma-
cological experiments with synthetic As-NLP-22 show that it is
a potent inhibitor of acetylcholine (ACh)-induced contraction
of A. suum muscle, and that it induces paralysis in intact
behaving worms.
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A search of nematode expressed sequence tag (EST) librar-
ies for As-NLP-22-like peptides identified predicted homolo-
gous peptides in several parasitic and free-living species, in-
cluding C. elegans. Because of its inhibitory effects on muscle
and its apparent ubiquity among nematodes, it promises to be




Live A. suum were collected from pig intestines at a slaughter-
house and maintained in phosphate-buffered saline (PBS,
140 mM sodium chloride, 10 mM sodium phosphate, pH
6.8–7.5) at 37°C. The PBS was changed daily and worms were
used within 3 d of collection.
Sample Preparation for Mass Spectrometry
Adult female A. suum were injected with 0.1–0.3 mL of
2 mg/mL collagenase (Sigma Blend H; Sigma, St Louis,
MO, USA) in Ascaris saline [4 mM sodium chloride,
125 mM sodium acetate, 24.5 mM potassium chloride,
5.9 mM calcium chloride, 4.9 mM magnesium chloride,
5 mM 3-(N-morpholino) propanesulfonic acid (MOPS)
buffer, pH 6.8] and incubated for 1.5–2 h at 37°C to
dissociate the muscle tissue. A 6–7 cm portion of the
worm anterior to the gonopore was removed and trans-
ferred to a Sylgard-lined dish. After cutting longitudinal-
ly between the dorsal nerve cord and the right lateral
line, the preparation was pinned open, the lips were cut
off, and the pharynx was removed. The preparations
were rinsed three times with 170 mM ammonium acetate
before the isotonic glycerol dissecting solution was
added (170 mM ammonium acetate in 30% glycerol
[47–50]). Dissecting needles made from electrolytically-
sharpened tungsten wire were used to isolate a desired
neuron from the many neuronal processes and hypoder-
mis in which it is embedded. For better visualization,
some preparations were bathed in 0.8 mM Methylene
Blue in 170 mM ammonium acetate for 20–30 s, then
cleared with 170 mM ammonium acetate, and dissected
as described above.
Isolated cells were transferred to a Bruker MTP stainless
steel MALDI target (Bruker Daltonics, Billerica, MA, USA).
Cells were cleared with 0.5 μL isopropanol [51] to remove the
glycerol and any remaining extracellular salts. Individual neu-
rons were spotted with 60–100 nL of saturated α-cyano-4-
hydroxycinnamic acid (CHCA; Sigma) in 70% acetonitrile
(ACN; Fisher Scientific, Waltham, MA, USA), 1%
trifluoroacetic acid (TFA; Sigma), or saturated 2,5-
dihydroxybenzoic acid (DHB; Sigma) in 1:1 HPLC grade
methanol and water (Fisher Scientific) using a Nanoliter Cool
Wave Syringe II [52].
Mass Acquisition
A Bruker Ultraflex III MALDI-TOF/TOF MS (Bruker
Daltonics) equipped with a Smartbeam laser and LIFT-TM cell
was used to obtain MS and MS/MS spectra with Bruker Com-
pass v. 1.2 software. Because the cells contain relatively small
quantities of peptide, all spectra were obtained from 50 laser
shots per acquisition. MS spectra were obtained in positive ion
reflectronmode, with anm/z range of 500–4000Da. Instrument
settings were optimized for maximum detection sensitivity
using the Bruker Flex Control software: ion source 1 voltage,
25.0 kV; ion source 2 voltage, 20.5 kV; reflector 1 voltage,
26.5 kV; reflector 2 voltage, 14.5 kV; lens voltage, 9.5 kV.
Synthetic peptide standards were not suitable for calibration of
the instrument because the laser intensity needed for analysis of
single cells was often far too high when analyzing pure stan-
dard, making it impossible to identify the monoisotopic peak of
the ion needed for accurate calibration. Therefore, a reference
spectrum from a freshly dissected A. suum AVK neuron, with
known peptide peaks [23], was used for external calibration of
the instrument.
Acetylation of Peptides
Following deposition of the cell onto the target surface, 0.5 μL
of isopropanol was applied to each cell to wash away the
glycerol solution, followed by 0.5 μL of methanol/ acetic
anhydride (3:1). The cells were allowed to dry before each
wash. Cells were then covered with matrix as described above.
Oxidation of Peptides
In cells exposed to Methylene Blue, methionine residues were
partially oxidized to the sulfoxide, with a mass shift of +16 Da,
and tryptophan residues gave rise to +16 and +32 adducts [41].
Assignment of Peaks and Interpretation of Mass
Spectra
Spectra were analyzed using Bruker Daltonics flex-Analysis
3.0 software. The software automatically assigned masses to
peaks in eachMS spectrum. EachMS/MS spectrum underwent
background subtraction and smoothing before the automatic
assignment of masses. In some cases, peak m/z values were
addedmanually. Peaks were considered significant if they were
twice the intensity of the baseline noise.
Molecular masses and ion fragmentation patterns were cal-
culated by Protein Prospector MS-Product (http://
prospector.ucsf.edu). Spectra containing peaks withm/z values
corresponding to masses ±0.2 Da of known A. suum peptides
were temporarily assigned. Confirmation of the assignments
was carried out by MS/MS and chemical modifications to the
peptides.
De novo sequencing of unidentified peaks was carried out
by hand. To establish the b series (N-terminal) and y series (C-
terminal) ions for each MS/MS spectrum, candidate b2 and y1
ions were chosen as a starting point for sequencing. To grow
each ion series, the annotation function in the flex-Analysis
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software was used to calculate the distance between adjacent
peaks to identify each amino acid until the full sequence was
deduced in both directions. The sequence was entered into
Protein MS-Prospector and the spectrum was analyzed for the
complete set of sequence ions, including internal fragments and
immonium ions. Verification of peptide sequence was carried
out by comparing the experimental MS/MS spectrum with that
of synthetic peptide. Further verification was carried out by
comparing sequences to tBLASTn searches and cloning of
A. suum gene sequences. Raw spectral image files were trans-
ferred to Adobe Illustrator (San Jose, CA, USA) for annotation.
Database Searches
Database searches were conducted using methods described in
recent publications [23, 41, 42]. Briefly, all predicted peptide
sequence assignments were searched using tBLASTn (Nation-
al Center for Biotechnology Information [NCBI], Bethesda,
MD, USA; http://www.ncbi.nlm.nih.gov/BLAST/) against
A. suum ESTs and a library of 447,546 genomic survey se-
quences (GSS). For all searches, program settings were mod-
ified for searching short sequences using a word size of 2, an E
value of 20,000, and a PAM30 matrix. Search results were
translated using the ExPASy Translate tool (http://
au.expasy.org/tools/dna.html) and examined for putative pep-
tide cleavage sites, and then for C-terminal glycine for C-
terminal amidation of peptides. Genomic sequences were ana-
lyzed for mRNA splice sites directly by PCR cloning of the
mRNA sequences and compared with genomic sequences [53].
Signal peptides were predicted using SignalP 4.0 (http://
www.cbs.dtu.dk/services/SignalP/).
Peptide Synthesis
Peptides were synthesized (Fmoc chemistry) by the University
of Wisconsin-Madison Biotechnology Center (UWBC). The
integrity of the synthesis was monitored by MALDI-TOF MS
and HPLC.
RNA Isolation and cDNA Preparation
Twenty-thirty A. suum heads were flash-frozen in liquid nitro-
gen and ground to a fine powder. Total RNAwas isolated using
a Nucleospin Nucleic Acid Purification Kit (Clontech, Moun-
tain View, CA, USA). First strand cDNA was generated for
PCR using a Superscript First Strand Synthesis System for RT-
PCR (Life Technologies, Grand Island, NY, USA). Rapid
amplification of cDNA ends (RACE)-ready cDNA for 5′- and
3′-RACE was created from total RNA using a SMARTer
RACE cDNA amplification kit (Clontech) according to the
manufacturer’s instructions.
Transcript Identification by PCR and RACE
To obtain information about the transcript that encoded this
peptide, primers were designed for PCR and RACE from
sequences in the A. suum EST library (accession no.
BI593877). RACE reactions were performed using an
Advantage 2 PCR Kit (Clontech) according to the manufac-
turer’s instructions with the 5′RACE primer nlp22-5RACE3
(5′-GTGCACACGATCCACAAAGCCTTCGAAA-3′) and 3′
RACE primer nlp22-3RACE (5′-CAAAACGCTCCTTAGC
TAGCGGTCGTTG-3′). The PCR reaction was performed
using the forward primer nlp22-3RACE2 (5′-GCTCGTTGCT
TGCGGTGCTCTTCGTTTCGAT-3′) and the reverse primer
nlp22-5RACE (5′-CCCATCGAGGCCAAGTTCGTCAGT
ATAAATCG-3′) in a 50 μL reaction as follows: 2 μL of
A. suum cDNA or 2 μL of cDNA reaction solution with no
reverse transcriptase as a control, 5 μL of 10X PCRGold buffer
(Applied Biosystems, Foster City, CA, USA), 2-8 μL of
25 mM MgCl2, 1 μL each of 10 mM dNTPs, 1 μL of each
primer (20 μM), and 0.25 μL of AmpliTaq Gold Polymerase
(Applied Biosystems; 5 U/μL). The PCR conditions were
programmed into the Eppendorf Mastercycler Gradient as fol-
lows: 95°C for 3 min, followed by 40 cycles of 94°C for 30 s,
66°C or 68°C for 30 s, 72°C for 1 min.
PCR and RACE products were run on a 1% agarose gel, and
novel bands were excised and purified using a Qiaquick Gel
Extraction Kit (Qiagen, Chatsworth, CA, USA). The purified
products were cloned into E. coli using a TOPO TA Cloning
Kit (Invitrogen, Carlsbad, CA, USA), and the plasmid DNA
was isolated with a Qiagen Miniprep Kit. Automated sequenc-
ing was carried out by the DNA Sequencing Facility at the
UWBC. Sequence electropherograms were viewed on
Chromas Lite software (Technelysium Pty. Ltd., South Brisbane,
Australia). Sequenceswere analyzed using the ExPASyTranslate
Tool and T-Coffee Multiple Sequence Alignment Tool (Swiss
Institute of Bioinformatics, Lausanne, Switzerland), and signal
peptide sequences were identified using SignalP 4.0.
Riboprobe Synthesis
The As-nlp-22 specific riboprobe was created using primers
nlp22-3RACE2 and nlp22-5RACE for PCR as described
above. Products were cloned and sequenced to confirm the
fidelity of the sequence and to determine the orientation of
the insert in the vector. The target sequences of the riboprobe
are shown in Figure 3b. The constructs were linearized using
restriction enzymes NotI and SpeI (New England Biolabs,
Beverly, MA, USA). Linearized plasmids were used as a
template to synthesize an antisense (experimental) and a sense
(negative control) digoxigenin-labeled riboprobe (Maxiscript
SP6/T7 kit; Ambion, Austin, TX, USA; digoxigenin-11-dUTP;
Roche Applied Science, Indianapolis, IN, USA) as previously
described [54]. To remove unincorporated nucleotides, the
reactions were run through NucAway Spin Columns
(Ambion). Probe integrity and concentration were determined
by gel electrophoresis with Sybr Gold staining (Molecular
Probes, Eugene, OR, USA) and nylon membrane dot blots
(Roche Applied Science protocol).
Localization of As-nlp-22 by In Situ Hybridization
A. suum whole mount preparations were prepared by injecting
large female worms with 0.1–0.3 mL of 2 mg/mL collagenase
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in autoclaved Ascaris saline and incubating in a beaker of PBS
at 37°C for 1.5–2 h. The anterior 6 cm of the worm was taken
and rinsed in autoclaved 100 mM phosphate buffer (pH 7.4)
and the heads were transferred to a Sylgard-coated dissecting
dish. The heads were cut longitudinally between the dorsal
nerve cord and the right lateral line, the lips were removed,
and the heads were pinned flat. Any remaining muscle cells
were gently removed with forceps. The preparations were
rinsed several times in 100 mM phosphate buffer and fixed in
1% paraformaldehyde in 100mMphosphate buffer (pH 7.4) on
a rocking table at 4°C overnight.
After fixation, the head preparations were processed as
previously described [54], with the following modifications:
incubation in proteinase K solution was increased to 30 min at
37°C, and staining was allowed to occur for up to 16 h in the
dark, or until staining of the cells was evident and background
staining began to occur. The staining reaction was stopped with
Milli-Q water, and the heads were rinsed with Milli-Q water (2
× 10 min). The preparations were mounted in Clear-Mount
(Electron Microscopy Sciences, Hatfield, PA, USA) and
allowed to dry. Microphotographs were taken with a Zeiss
AxioCam MRc camera on a Zeiss Universal microscope.
Characterization of As-NLP-22 Bioactivity
in Muscle Strips
Strips of dorsal muscle were obtained by cutting large
female A. suum longitudinally along the lateral lines and
isolating a 2 cm strip approximately 1 cm posterior to
the head. Each preparation contained dorsal muscle cells
(all longitudinal) and the motor axons of the dorsal nerve
cord. The ends of the preparation were tied with silk
thread. One end was attached to a fixed hook in a 7 mL
chamber containing normal Ascaris saline stirred by bub-
bling nitrogen gas, and the other end was tied to a
FORT25 force transducer (World Precision Instruments,
Sarasota, FL, USA). The output of the transducer was
routed through a TBM4M transbridge (World Precision
Instruments) and recorded on a computer using Data-
Trax or LabScribe2 software (World Precision Instru-
ments), and the data were analyzed for tension/time
relationships.
Baseline contractions were measured by adding 5 μM ACh
to the chamber by micropipette, followed by rinses of Ascaris
saline. The preparation was then exposed to 10 μM peptide
solution in Ascaris saline for 10 min. The chamber was rinsed,
fresh peptide was added, and ACh-induced contraction was
measured by adding 5 μM ACh immediately after exposure to
peptide solution, followed by rinses with peptide-free Ascaris
saline. Muscle strip contraction in response to ACh was mea-
sured at 10, 20, 30, 40, and 50 min after exposure to peptide,
with rinses of peptide-free Ascaris saline between doses of
ACh. For comparison, control muscle strips were subjected to
ACh-induced contraction in peptide-free Ascaris saline at the
same time points. Responses of the muscle strips were reported
as a percentage of the maximum ACh contraction observed for
each muscle strip. A dose–response curve was created by
repeating the procedure described above with peptide concen-
trations of 10 μM, 1 μM, 100, 10, 1, 0.1, 0.01 nM and
comparing the results to control muscle strips.
Statistical Analysis
Contractile responses and baseline tension were reported as the
mean ± SE for each peptide concentration and displayed in
Prism 6 software (GraphPad, San Diego, CA, USA). Statistical
significance between peptide and control trials was determined
using unpaired t-tests, with significance levels set at P < 0.05 or
P < 0.01. The IC50 was calculated using the four-parameter
logistic (4PL) curve and Prism 6 software, with constants
estimated by nonlinear regression.
Characterization of NLP Effects in Intact Worms
To examine the broader behavioral responses associated
with neuropeptides, we used the whole worm injection
assay [55]. Worms used in this assay are allowed to move
freely inside an 18-mm-diameter × 41-cm-long glass tube
filled with PBS at 37°C and closed off with rubber
stoppers. This tube is similar in diameter to the porcine
small intestine, which is the natural habitat of these
worms. The worms were allowed to acclimate to the
tube for 5 min, followed by 5 min of observation prior
to injection to establish a baseline for locomotory activity.
Then, the worms were partially removed from the tube
and injected with 0.1 mL of 10 μM peptide solution in
Ascaris saline, and placed back inside the tube. Handling
of the worms was kept to a minimum. Locomotory
activity was observed for 60 min post-injection, with
recorded observations grouped into 5-min increments.
Digital photos were captured with a Nikon D50 camera
at 5 min pre-injection, immediately before and immedi-
ately after injection, and at 5-min intervals post-injection.
Multiple Alignments
BLAST searches of the nematode EST library were performed
using both As-NLP-22 and Ce-NLP-22 as queries. Selected
sequences were imported into MEGA5.1 [56] for alignment by




The basic morphologic and physiological properties of adult
A. suum motorneurons have been well described [30], as has
their classic neurotransmitter phenotype [36, 37]. The somatic
motorneurons, which innervate the dorsal and ventral muscu-
lature, comprise seven morphologic and physiological types,
four (DE1, DE2, DE3, and DI) controlling dorsal muscle, and
three (VE1, VE2, and VI) controlling ventral muscle (Figure 1).
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The cell bodies of all these neurons are located in the ventral
nerve cord, and dorsal muscle is innervated via neural process-
es (commissures) that extend from the ventral to the dorsal
nerve cord. These seven types of motorneurons are analogous
to seven classes of motorneurons found in C. elegans [22, 30].
The dorsal and ventral excitors (DE and VE) are cholinergic
[36] and the corresponding inhibitors (DI and VI) are
GABAergic [34, 37]. These motorneurons occur in repeating
patterns along the length of the worm, such that each of the five
“segments” includes 11 motorneurons, four of which (DE1,
VE1, VE2, and VI) are present in two copies, with only a single
copy of DE2, DE3, and DI [30].
Cell identification relies on several features (see
Figure 1a, b). First, the DE1, DE2, and DE3 neurons
have commissures that emerge from the cell body; in the
case of the DE1 and DE2 neurons, the identification is
reinforced by the diameter of the commissure, which is
larger than that of the accompanying commissure from
an inhibitory neuron [36]. Second, the cell body of the
VI neuron is the next posterior cell body to the DE1/VI
commissure pair. The cell body of the DI motorneuron is
posterior to the DE2/DI commissure pair; the relative
position of the DE3 and DI cell bodies is variable, but
DE3 is recognized by the commissure emerging from its
cell body. Five of these types (DE1, DE2, DE3, DI, and
VI) have been investigated electrophysiologically, and
their properties are unusual [59]. None of these neurons
conducts action potentials; instead they have high mem-
brane resistance, which enables them to signal passively
over long distances. They have long processes (axons)
Figure 1. Schematic of the ventral cord motorneurons of A. suum. (a) Diagram of the ventral nerve cord adapted from Stretton et al.
(1978) showing the position and handedness of themotorneuron commissures. The ventral nerve cord is represented by the vertical
line. Right- and left-handed commissures leave the cord in an ordered array, indicated by the horizontal lines. Arrows show the
positions of the nerve ring and tail ganglia. Some of the commissures at the anterior end of the ventral cord have been omitted for
clarity. (b) Stereotypical pattern of motorneuron cell bodies found in each segment (segments 2–5) and their associated commis-
sures. This figure shows the third segment. Filled circles indicate cell bodies of excitatory motorneurons. Open circles indicate cell
bodies of inhibitory motorneurons. DE1 and DE2 commissures have a larger diameter than the inhibitory commissures with which
they are paired [36]. (c), (d) Schematic of the seven types of (c) A. suum, and (d) C. elegans segmental motorneurons. Filled circles
indicate cell bodies, all found in the ventral nerve cord (V). Vertical lines emanating from the cell body represent the ventral nerve cord
processes, and horizontal lines represent commissures that connect dorsal (D) and ventral processes. Forked projections represent
axonal synapses onto muscle
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within the nerve cords, and synapse onto muscle cells
along the length of the axon, providing synaptic input to
muscle cells over a distance of several centimeters [32].
Dissection of Single Motorneurons
Initially, the dissection of single motorneurons from the ventral
nerve cord was difficult because of the close association with
hypodermis and the other processes within the nerve cords. The
use of an isotonic dissecting solution containing glycerol has
permitted the isolation of all the cell bodies of the
motorneurons in any chosen length of the ventral nerve cord
with minimal contamination from surrounding tissue [47]. The
mass spectra of different individual cells are highly distinctive,
but they fall into classes that correspond to morphologic and
physiological subtypes. The peptides present are few in num-
ber, and individual peptides can readily be isolated as single
peaks for subsequent sequencing by tandem MS. Once the
sequence has been established, the peptide can be synthesized
and tested for its bioactivity. Sequence information also en-
ables searches of EST databases for the encoding transcript,
which can then be cloned and used to design and synthesize
gene-specific mRNA probes for in situ hybridization (ISH). In
all cases, ISH has confirmed the expression of the peptide-
encoding transcript in the identified motorneuron that contains
the peptide itself. ISH also determines the expression of the
transcript in other neurons throughout the entire nervous
system.
Peptide Characterization by MS of Single Inhibitory
Ventral Cord Motorneurons
From the ventral cord (VC), the cell bodies of individual VI and
DI neurons were dissected from the anterior three segments of
the worm (Figure 1a, b) and analyzed byMALDI-TOF MS for
their peptide content. Spectra from VI and DI were virtually
identical, each containing only two intense to moderate peaks,
which is relatively few compared with other cell types analyzed
in previous studies [23, 41]. All spectra from both VI and DI
neurons contained an intense peak withm/z of 1198.7. In 11/17
VI and 12/15 DI spectra, there were also smaller peaks withm/z
1256.7 (Figure 2a, b). Interestingly, direct tissue analysis by
MS on a dissected portion of the A. suum ventral nerve cord,
which included ventral cord inhibitory motorneuron cell bodies
and their neurites, indicated the presence of both peaks, among
many others, but they had not been previously sequenced [40].
In MALDI-TOF MS, certain on-target chemical modifica-
tions are straightforward, and can identify functional groups in
peptides. For example, in some preparations, cells were briefly
stained with Methylene Blue to aid in cell identification during
dissection (see Materials and Methods). Exposure to Methy-
lene Blue has been shown to partially oxidize methionine
residues to the sulfoxide, causing a +16 shift in m/z; to a lesser
extent, tryptophan residues may be oxidized to give +16 Da or
+32 Da adducts [41, 60]. In three of 17VI spectra and one of 15
DI spectra we observed a small peak with an m/z of 1214.7
(1198.7 + 16) and another at 1230.7 (1198.7 + 2×16) (data not
shown). These minor peaks suggested the presence of a
Figure 2. Neuropeptides from single ventral cord inhibitory motorneurons. (a), (b) Mass spectra from individual (a) VI and (b) DI
neurons. (c), (d) Spectra from individual (c) VI and (d) DI neurons treated with acetic anhydride each causing a +42 Da mass shift. In
these peptides, only the N-terminal α-amino group is substituted
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tryptophan residue. On-target acetylation produced a mass shift
of +42 Da for both the 1198.7 and 1256.7 peaks, consistent
with the presence of a single amino group in each peptide
(Figure 2c, d).
The 1198.7 ion was selected for sequencing by tandemMS.
De novo interpretation of spectra was done by hand and yielded
the sequence S(I/L)ASGRWG(I/L)RPamide (Figure 3a). At
this time, the MALDI-TOF/TOF technology is unable to re-
solve the isoleucine (I)/leucine (L) ambiguity because the two
amino acids are isobaric. A BLAST search of the A. suum EST
library produced the sequence SLASGRWGLRPG (Genbank
accession no. BI593877), which is orthologous to the Ce-NLP-
22 peptide found in C. elegans [44]. Because it is the A. suum
version, we refer to it as As-NLP-22. The peptide is flanked by
dibasic putative cleavage sites and the C-terminal glycine is
known to be a substrate for post-translational amidation; thus,
the predicted peptide product from the precursor protein is
SLASGRWGLRPamide. The MS/MS fragmentation pattern
contained nearly the full set of b- and y-ions with an additional
set of internal ion fragments. MS/MS spectra of synthetic As-
NLP-22 peptide produced a fragmentation pattern nearly iden-
tical to that of the native peptide (Figure 3). In MS/MS spectra
from both VI and DI neurons, we noticed a single intense peak
at m/z 1156.7 (MH+ – 42 Da). Typically, the loss of 42 Da is
due to loss of an acetyl group from a peptide that has been post-
translationally acetylated. Knowing this was not a plausible
explanation in this case, we hypothesized that the peak was due
to the neutral loss of the C-terminal proline side chain
Figure 3. Identification of novel peptide As-NLP-22 in the dorsal and ventral inhibitorymotorneurons. (a- upper spectrum)MS/MSof
them/z 1198.7 peak froma single DImotorneuron. (a- lower spectrum)MS/MSof synthetic form of As-NLP-22 reveals nearly identical
fragmentation pattern. Peaks representing a- (dark green), b- (blue), y- ions (red), and internal fragments and immonium ions (light
green) are labeled. b- and y-ions are summarized in the sequence at the top of the spectrum. Peaks with the m/z 104.1 and 184.1
from the fragmentation of a PC head group are seen in MS/MS spectrum of native As-NLP-22, but not that from the synthetic
peptide (purple). (b)Nucleotide sequence of the As-nlp-22 transcript, deduced by 5′ and 3′RACEand confirmed by PCRusing unique
primers underlined in black (Genbank accession no. KF483662). Green amino acids indicate the signal peptide, with the putative
start site in bold. Blue amino acid sequence indicates the encoded peptide, flanked by dibasic cleavage sites in bold. Bolded
nucleotide sequence is the portion of the transcript targeted by the As-nlp-22 riboprobe. Red bases indicate start of exon 1, and the
vertical red line showswhere two exons are joined together. (c) As-nlp-22genemodel. The gene consists of two exons of 104 and 260
bases, respectively. Exons are separated by an intron 5073 bases in length
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(CH2CH2CH2). To test this hypothesis, we performed MS/MS
on four additional synthetic peptides with C-terminal prolines,
in both the amidated and carboxyl forms, and with variable N-
terminal extensions (Online Resource 1). In all cases, an in-
tense peak at MH+– 42Da was observed, supporting our
hypothesis.
In comparing the MS/MS spectra of natural and synthetic
As-NLP-22, there was a striking difference, the presence in the
natural peptide spectrum of a strong peak at m/z 184.1, and a
somewhat less intense peak at m/z 104.1 (Figure 3a). Such
peaks have been observed previously in MS/MS spectra of
peptides from single neurons [23, 41]. In each case, including
the present example of As-NLP-22, the MS/MS spectra of
synthetic peptides lacked these peaks. Our present hypothesis
is that this peak is phosphocholine (PC: [M + H]+ 184.073
predicted; 184.069 observed), and that the peak at m/z 104.1 is
choline. This is supported by the following data. First, the
isotopic patterns of this peak are identical with those predicted
for PC, and distinct from those of peptides. Second, when
synthetic peptide was applied to a MALDI-TOF target plate
in the presence of a single dissected neuron (AVK; [23]), MS/
MS spectra were obtained both from the zone with pure pep-
tide, and from the region that included the dissected neuron.
The results showed that the m/z 184.1 and 104.1 peaks only
occurred in the region adjacent to the neuron. The differences
in the spectra were just like those illustrated in Figure 3, show-
ing the same distinctive peaks in the natural and synthetic
peptides. At present, it is unclear why PC is found in MS/MS
spectra, since it would be expected that any ions but those
chosen from the MS spectrum for fragmentation would be
selectively removed. However, the fact that these peaks are
routinely found in spectra of natural peptides, but not of their
synthetic versions, suggests that this is a common problem. PC
is an abundant naturally occurring component of nematode
cells since it is used directly as a precursor to phosphatidylcho-
line [61].
The most likely interpretation of the presence of a peptide
with m/z 1256.7 is that it is a processing intermediate in the
formation of mature As-NLP-22. Its mass is exactly 58 Da
more than As-NLP-22, which is explained by the addition of
57 Da from the glycine residue and 1 Da from the mass
difference between a C-terminal carboxylic acid and a C-
terminal amide. The presence of processing intermediates is
not surprising, since the MS analyses are carried out on neuro-
nal cell bodies, where the rough endoplasmic reticulum and the
Golgi apparatus, the first sites of processing, are located;
processing is completed within the secretory vesicles [29,
62, 63]. C-terminal amidation is the last step in the
processing of these peptides, following proteolytic cleav-
age, trimming by carboxypeptidase and, finally, oxidation
of C-terminal glycine residues, leading to the removal of
both the carboxyl and α-carbon of glycine, and leaving
the amino group as a C-terminal amide. Perhaps it is
surprising that these intermediates are not seen more
often. In many neurons previously analyzed, no trace of
the glycine form of a processed peptide has been
detected, although in a few cases, namely the glycine-
adduct of AF2 and AF8, the intermediates were detected
by MS [42].
A possible explanation of the detection of the glycine adduct
in inhibitory motorneurons is that the peptide complement of
these cells is very simple, essentially peptide As-NLP-22 and
its G adduct; perhaps this simplicity might affect the
ionizability of the peptides present during the MALDI process.
Unrefined MALDI-TOFMS, such as we have used, is far from
being a quantitative technique, and the presence or even the
absence of a peptide peak depends not just on the ionizability
and concentration of the peptide but also on the complexity of
the mixture of peptides present, as manifested in the phenom-
enon called ion suppression [64]. However, the AF2 and AF8
adducts were detected in much more complex mixtures than
that found in the inhibitory motorneurons, making it less likely
that suppression is affecting the detectability of G-adducts in
general. Perhaps there is an effect of sequence on the efficiency
of the amidating enzyme complex, or a difference in the ex-
pression levels of enzyme and substrate in different neurons
affecting the efficiency of amidation. A thorough analysis of
the kinetic properties of the A. suum amidating enzyme com-
plex and its activity on different substrates would be useful.
Another example of incomplete processing observed in
A. suum neurons is incomplete proteolysis, often involving
KK cleavage sites [40–42], which apparently are cleaved more
slowly than KR or R sites [23, 65]. Proteolytic cleavage is
known to bemore complex than amidation: inC. elegans, there
are multiple proteases involved, and the cellular expression of
these enzymes is not known. Local sequence around the cleav-
age sites and the three-dimensional structure of the precursor
protein are also possible factors that may affect cleavage spec-
ificity and efficiency.
Cloning of the As-nlp-22 Transcript
To clone the peptide-encoding transcript, we initially used
primers specific to SL1, a splice leader sequence on ca. 80%
of the known A. suum transcripts [66], together with a gene-
specific reverse primer, but were unsuccessful. However, the
use of 5′ and 3′ RACE with 5′RACE primer nlp22-5RACE3
and 3′RACE primer nlp22-3RACE allowed us to identify the 5′
and 3′ regions of the transcript, and to identify a 385 base
product. To fuse the two RACE product sequences and confirm
the validity of the overlapping regions, a full-length PCR
reaction was performed using the forward primer nlp22-
3RACE2 and the reverse primer nlp22-5RACE. The deduced
amino acid sequence contains an 80 amino acid open reading
frame, complete with an initiating methionine N-terminal to a
predicted signal peptide, a single copy of the peptide flanked by
dibasic cleavage sites, and a 3′ polyA tail (Genbank accession
no. KF483662) (Figure 3b). Analysis of genomic sequences
showed that the As-nlp-22 gene is composed of two exons.
Exon 1 comprises 104 bases and includes the entire signal
peptide region, whereas exon 2 comprises 260 bases and in-
cludes the peptide-encoding region. The two exons are
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separated by an intron of 5073 bases (Figure 3c). There is no
evidence that this transcript is trans-spliced to SL1.
Localization of the As-nlp-22 Transcript by In Situ
Hybridization
To confirm the presence of the As-nlp-22 mRNA in
GABAergic VI and DI ventral cord motorneurons, we
used primers nlp22-3RACE2 and nlp22-5RACE to syn-
thesize a 179 base antisense riboprobe (Figure 3b). As a
negative control, a sense strand probe was also synthe-
sized. In the first two to three segments of the 30 worms
analyzed, 96% of the DI and VI motorneurons present
showed moderate to intense staining when exposed to the
antisense probe (Figure 4b, c). No staining was observed
in the negative control preparations (data not shown).
Interestingly, we also observed a pair of bilaterally sym-
metrical stained cells in the posterior portion of the
ventral ganglion (Online Resource 2a), thought from
their position and size to be either AIY or AIM (these
neurons are immediate neighbors in the ventral ganglion
and have indistinguishable morphology by light micros-
copy). MS spectra of individual cells dissected from this
pair contain peaks at m/z 1198.7 and 1256.7, suggesting
that they contain authentic As-NLP-22 and the As-NLP-
22+G adduct (Online Resource 2b). As in the VI and DI
neurons, strong GABA-like immunoreactivity has been
detected in one of the AIY/AIM pair [34] but, again,
they have not been definitively distinguished from each
other. We speculate that GABA and As-NLP-22 co-
localize in AIY or AIM as they do in the inhibitory
ventral cord motorneurons, but more experiments will
be needed to test this. If confirmed, it would strengthen
the argument that As-NLP-22 and GABA are often co-
expressed, and that As-NLP-22 may be important in the
GABA signaling pathway.
Bioactivity
(1) Muscle Strips We submitted the peptide As-NLP-22 to
functional analysis by measuring its effects on ACh-induced
contraction in strips of A. suum dorsal muscle, using standard
protocols from this laboratory [67, 68]. Exposure to a single
dose of 10 μM peptide practically abolishes any contractile
response to ACh (2.1% ± 0.4% of the pre-peptide response, n =
8 preparations, P < 0.01). Once the peptide was washed out, a
gradual partial recovery (~15%) was observed over 50 min
(Figure 5a). Additional concentrations (1 μM, 100, 10, 1, 0.1,
0.01 nM) of As-NLP-22 were tested to determine the IC50. A
dose-dependent inhibition was observed at all concentrations,
followed by a variable extent of recovery once peptide was
washed out. A dose–response curve was made by plotting the
response in the presence of As-NLP-22 at all seven concentra-
tions as a percentage of the control (Figure 5b). As-NLP-22
exhibits a strong and prolonged inhibitory effect on ACh-
induced dorsal muscle strip contraction with an IC50 of 8.3 ×
10–9 M.
We also observed dose-related peptide effects on baseline
muscle tension, observed at the end of the 10 min exposure to
peptide. The threshold for this effect was between 10–9 and
10–8M; the reduction in tension was 1.2 ± 0.2 g, 1.9 ± 0.4 g, 2.2
± 0.3 g, and 2.6 ± 0.3 g at peptide concentrations of 10–8, 10–7,
10–6, and 10–5 M, respectively. After the peptide was washed
out, there was no significant reversal of baseline tension to
control levels.
(2) Behavioral Effects of Injection of Peptides into Intact
Worms To determine the effects of As-NLP-22 on gross
locomotory behavior, we injected intact worms with synthetic
peptide and observed their behavior in a glass tube with diam-
eter comparable to that of the porcine small intestine, which is
the natural habitat of the adult worms. A. suum maintain their
position in the small intestine by bracing against the walls with
Figure 4. Expression of As-nlp-22 as determined by ISH. (a) Diagram of A. suum ventral cord motorneurons in one of the repeating
units. Indicated in red (VI) and green (DI) are the cell bodies of neurons shown in b and c. (b) VI neuron cell body stained with the As-
nlp-22 riboprobe (red arrow). (c) DI neuron cell body stained with the As-nlp-22 riboprobe (green arrow). Scale bars: 100 μm
2018 C. J. Konop et al.: Ascaris Inhibitory Neuropeptide
pseudo-sinusoidal body waveforms (produced by alternating
dorsal and ventral contraction and relaxation of the somatic
musculature). These waveforms propagate in the anterior or
posterior direction to control forward or backward locomotion,
respectively. Anteriorly-propagating waves can be induced by
tying surgical thread tightly around the head, producing a
stereotypical behavioral response called Head-Restricted Be-
havior [55, 69, 70]. Peptide solutions can then be injected into
the pseudocoelomic cavity posterior to the ligature, and any
changes in locomotory behavior recorded.
Injection of 10 μM As-NLP-22 into ligatured worms
abolished all locomotory activity posterior to the ligature and
decreased body tonus, resulting in flaccid paralysis (n = 10;
Figure 5c). These worms did not recover appreciably even after
60 min post-injection. This response is in stark contrast to
control worms, injected with Ascaris saline, which produced
normal anteriorly-propagating waves for the duration of the
experiment (n = 13). Similarly, worms injected with 0.1 μM
As-NLP-22 displayed a reduction in the number of anteriorly-
propagating waveforms in the body of the worm and in their
amplitude, although the results were more variable than the
10 μM trials. Seven of ten worms injected with 0.1 μM As-
NLP-22 produced no anteriorly-propagating waves; of these,
five exhibited paralysis within 5–10 min post-injection. The
remaining 3/10 worms showed no obvious impairment in
locomotory behavior. Previous experiments showed that dye
solution is diluted ca. 10-fold upon injection into the
pseudocoelomic fluid [55], so the peptide concentration
resulting from a 0.1 μM As-NLP-22 injection approximates
the IC50 concentration (8.3 × 10
– 9M) deduced from themuscle
strip assay. Since the IC50 is the concentration that produces
50% of the maximal response, this could account for the
variable behavioral responses observed in these trials.
We also made injections of As-NLP-22 into unligatured
worms, at concentrations of 10, 1, and 0.1 μM, with similar
results (not shown), suggesting that the neurons of the head
and nerve ring do not play an important role in the peptide
response. In these worms, as in the ligatured worms, no effects
on the three-dimensional head-searching movements were
observed.
Comparison with Other Nematodes
It is estimated that the origin of nematode speciation was about
500 million years ago [71]. Nematodes vary dramatically in
size and in the ecological niche that each inhabits, yet their
basic body plans are highly conserved and the general
Figure 5. Effects of As-NLP-22 on ACh-induced muscle contraction and gross locomotion. (a) Effects of single exposure to
synthetic As-NLP-22 on ACh-induced muscle contraction. Peptide was introduced at 0 min and washed out at 10 min, depicted by
the shaded region. Strength of contraction is normalized to the initial contraction prior to the application of peptide for each individual
worm. Error bars represent standard error of the mean. At concentrations denoted with asterisks, responses were significantly
different fromcontrol worms at all time points (**P < 0.01, *P < 0.05). (b)Dose-response of As-NLP-22. Each data point represents the
response in the presence of peptide, expressed as a percentage of the control response. IC50 = 8.3 × 10
–9M. (c) Injection of As-NLP-
22 into intact worms causes reduced locomotory behavior. Control worms injected with Ascaris saline showed no discernible
impairment in locomotory activity (n = 13). Worms injected with 10 μM As-NLP-22 displayed paralysis for the duration of the
experiment (n = 10). Worms injected with 0.1 μMAs-NLP-22 (approximates IC50 in vivo) displayed a general reduction in locomotory
behavior (n = 10), though the behavioral responses were more varied than the 10 μM trials
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architecture of nematode nervous systems is very similar. The
detailed cellular morphology of neurons has only been deter-
mined in two species, A. suum and C. elegans, which have
vastly different life styles: A. suum is an intestinal parasite
about 30 cm in length, whereas C. elegans is a free-living soil
nematode, ca. 1 mm in length. The morphology of homologous
neurons is virtually identical for both the motorneurons
(Figure 1c, d) as well as the other neurons in the nervous
system; they differ in size. The expression of classic transmit-
ters in the motorneurons is also highly conserved, with excitors
using ACh and inhibitors using GABA.
Structural conservation also extends to neuropeptide se-
quences. For example, there are four readily identifiable fam-
ilies of peptides, found in 22 other nematodes [72] that share a
C-terminal -RPamide sequence. As-NLP-22 belongs to one of
these, encoded by the As-nlp-22 gene. The three other families
are encoded by the nlp-2, -23, and -46 genes. Confirmation of
the peptide sequence of As-NLP-22 and cloning of its peptide-
encoding transcript suggests that A. suum SLAS
GRWGLRPamide is the homolog of Ce-NLP-22 and not Ce-
NLP-2 as was previously reported [42]. Homologous nlp-22
genes from other nematodes encode a predicted precursor pro-
tein that includes a single copy of the peptide with the charac-
teristic motif S[A/M/L]A[I/N/S]GR[A/M/W][G/Q][M/F/
L]RPG, flanked by dibasic or monobasic putative cleavage sites.
We conducted BLAST searches of nematode ESTs using
both As-NLP-22 and Ce-NLP-22 as queries and identified
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Figure 6. Multiple alignment of nematode nlp-22 transcripts by MEGA5.1 [56]. Results from 11 nematode species, organized
alphabetically by clade, were presented in Jalview [56, 58], and show strong conservation of the predicted encoded peptide and
signal peptide. Asu = Ascaris suum (Clade III); Sst = Strongyloides stercoralis (IVa); Aav = Aphelenchus avenae (IVb); Gro = Globodera
rostochiensis (IVb); Mar =Meloidogyne arenaria (IVb); Mch = Meloidogyne chitwoodi (IVb); Min = Meloidogyne incognita (IVb); Cbg =
Caenorhabditis briggsae (V); Cbr = Caenorhabditis brenneri (V); Cel = Caenorhabditis elegans (V); Cre = Caenorhabditis remanei (V)
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nematodes (Online Resource 3), doubling the number of nem-
atode NLP-22 encoding transcripts previously reported by
McVeigh et al., 2008 [72]. When sequences were aligned, they
fell into two groups differing slightly in their sequence within
the conserved nematode NLP-22 motif (Figure 6). Group 1,
from clades IVa and V [71, 73], was typified by a C-terminal –
FRPamide, whereas group 2, from clades III and IVb, were all
from parasitic species and shared a C-terminal –LRPamide
sequence. Sequences within members of a group were highly
conserved (group 1: SIAIGR[A/S]GFRPamide; group 2:
SLA[S/N]GRW[Q/G]LRPamide). The peptide from parasitic
nematode S. stercoralis is an exception; it appears to be an
amalgam of the two, sharing an N-terminal SL- with group 2
and C-terminal –AIGR[X]GFRPamide with group 1. Eventu-
ally, it will be interesting to see if these sequence differences
are correlated with functional differences, or if they are simply
markers of the phylogeny, with shared function.
Little is known about the specific cellular expression of
NLP-22 in other nematodes, with the exception of
C. elegans. Ce-nlp-22:GFP was shown to be expressed in the
pair of RIA neurons, head interneurons that regulate a nema-
tode sleep-like state known as lethargus [74]. Over-expression
of Ce-nlp-22 in adult C. elegans causes a decrease in locomo-
tion and feeding behavior. Although the structure of As-nlp-22
and Ce-nlp-22 are highly similar [72], their reported cellular
expression is completely different in the two species, with no
expression of Ce-nlp-22 in inhibitory motorneurons [74].
We have previously suggested that differences in cellular
expression of homologous peptides could be at least part of the
explanation of how organisms with virtually the same nervous
systems can generate different behaviors that enable them to
inhabit such different ecological niches. However, a note of
caution must be added, since in most cases the cellular localiza-
tion in C. elegans was determined by using GFP constructs that
included the promoter and various lengths of 5′ sequence. It is
known that sequences controlling gene expression can be remote
from the promoter and may also include sequences 3′ to the gene,
or intronic regions [75, 76], so it is difficult to know whether the
control sequences of the constructs are complete. Corroboratory
methods are badly needed. In A. suum, we have used in situ
hybridization to confirm the localizations observed by MS. Im-
portantly, both methods directly detect the gene products, either
the peptides themselves or the peptide-encoding transcript,
expressed in the normal worm, without any possible interference
in gene expression that could be induced by the introduction of
additional gene copies. In addition, in cases where we could raise
monospecific antibodies recognizing a single peptide [23], we
have used immunocytochemistry as a third technique that also
validates the cellular expression. For all three techniques, the
large size of A. suum neurons is an enormous advantage.
Conclusions and Future Experiments
This work identifies the first peptide expressed in A. suum
inhibitory motorneurons. As-NLP-22 is found in the VI and
DI inhibitory motorneurons of the ventral cord. We have dem-
onstrated that As-NLP-22 has a potent inhibitory effect on
ACh-induced muscle contraction and locomotory behavior.
At the moment, the cellular basis for the inhibitory action of
As-NLP-22 is unknown. Further investigation of As-NLP-22
by electrophysiological methods, to determine its mechanism
of action and postsynaptic partners, will add to the description
of the circuitry that controls locomotion and provide valuable
information on developing targets for effective drug treatments
of nematode parasites. We will also investigate potential inter-
actions between GABA and this peptide, since they are co-
expressed in the inhibitory motorneurons.
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